Filtros de búsqueda

Lista de obras de

820Triple Combination Treatment With Peginterferon Lambda-1a, Daclatasvir and Ribavirin for 12 Weeks in Patients Infected With HCV Genotype 1b.

artículo científico publicado en 2014

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

artículo científico publicado en 2018

A global view of hepatitis C: physician knowledge, opinions, and perceived barriers to care

artículo científico publicado en 2013

A personalized approach to optimize hepatitis B treatment in treatment-naive patients ⬇️

artículo científico publicado el 1 de enero de 2010

A phase 2 study of filibuvir in combination with pegylated IFN alfa and ribavirin for chronic HCV.

artículo científico publicado en 2014

A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B.

artículo científico publicado en 2004

A randomized, controlled study of peginterferon lambda-1a/ribavirin ± daclatasvir for hepatitis C virus genotype 2 or 3.

artículo científico publicado en 2016

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

artículo científico publicado en 2011

ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg-positive chronic hepatitis B.

artículo científico publicado en 2018

Accumulation of Intrahepatic TNF-α-Producing NKp44+ NK Cells Correlates With Liver Fibrosis and Viral Load in Chronic HCV Infection

artículo científico publicado en 2016

Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases.

artículo científico publicado en 2006

Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C.

artículo científico publicado en 2006

Acute hepatitis E with severe jaundice: report of three cases

artículo científico publicado en 2007

Acute pulmonary embolism

scientific article published on 01 November 2004

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

artículo científico publicado en 2003

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

artículo científico publicado en 2003

Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failure

artículo científico publicado en 2008

Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study

artículo científico publicado en 2011

Advances in therapy for chronic hepatitis B.

artículo científico publicado en 2002

All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study

artículo científico publicado en 2014

Allogeneic hematopoietic cell transplant in HCV-infected patients

artículo científico publicado en 2008

An Update in the Management of Chronic Hepatitis B ⬇️

artículo científico publicado el 3 de julio de 2013

Antiviral Activity of Danoprevir (ITMN-191/RG7227) in Combination With Pegylated Interferon α-2a and Ribavirin in Patients With Hepatitis C ⬇️

artículo científico publicado el 15 de agosto de 2011

Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC.

artículo científico publicado en 2006

Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease

scientific article published on 07 October 2008

Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis B.

artículo científico publicado en 2015

Auxiliary liver transplantation for fulminant hepatitis B: results from a series of six patients with special emphasis on regeneration and recurrence of hepatitis B.

artículo científico publicado en 2002

Avoiding and managing lamivudine resistance in chronic hepatitis B: current approaches and potential strategies including pegylated interferon

artículo científico publicado en 2010

Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort).

artículo científico publicado en 2015

Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients( ) ⬇️

artículo científico publicado el 1 de enero de 2012

Boceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null response

artículo científico publicado en 2013

Boceprevir for previously treated chronic HCV genotype 1 infection

artículo científico publicado en 2011

CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients

artículo científico publicado en 2011

Changes in autophagic response in patients with chronic hepatitis C virus infection

artículo científico publicado en 2011

Characteristics of patients with chronic hepatitis B in France: predominant frequency of HBe antigen negative cases.

artículo científico publicado en 2006

Chronic hepatitis B treatment initiation and modification patterns in five European countries: a 2-year longitudinal, non-interventional study

artículo científico publicado en 2013

Chronic hepatitis B: a global health problem requiring coherent worldwide treatment strategies

scientific article published on 06 June 2007

Chronic hepatitis B: back to the future with HBsAg

artículo científico publicado en 2009

Chronic hepatitis B: which patients should be treated and how?

artículo científico publicado en 2005

Clevudine: a promising therapy for the treatment of chronic hepatitis B

article

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

scientific article published on 11 February 2019

Clinical performances of two real-time PCR assays and bDNA/TMA to early monitor treatment outcome in patients with chronic hepatitis C.

artículo científico publicado en 2009

Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B.

artículo científico publicado en 2015

Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a

artículo científico publicado en 2008

Comparison of on-treatment HCV RNA during direct antiviral therapy using two different COBAS TaqMan HCV assays

artículo científico publicado en 2017

Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study

artículo científico publicado en 2018

Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort).

artículo científico publicado en 2015

Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.

artículo científico publicado en 2010

Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis

article

Corrigendum to “Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the ‘accordion’ regimen?” [J Hepatol 47 (2007) 580–587]

scholarly article published in Journal of Hepatology

Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.

artículo científico publicado en 2006

Cytokine--chemokine and apoptotic signatures in patients with hepatitis C.

artículo científico

Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C ⬇️

artículo científico publicado el 21 de septiembre de 2010

Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.

artículo científico publicado en 2016

Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C.

artículo científico publicado en 2014

Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients

artículo científico publicado en 2006

Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B.

artículo científico publicado en 2015

Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow ⬇️

artículo científico publicado el 1 de febrero de 2012

Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C.

artículo científico publicado en 2011

Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives

artículo científico publicado en 2016

Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B

artículo científico publicado en 2019

Dynamic evolution of therapy for chronic hepatitis C: how will novel agents be incorporated into the standard of care?

artículo científico publicado en 2008

Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy

artículo científico publicado en 2006

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients

article

Effect of newer oral antiviral agents on future therapy of chronic hepatitis B.

scientific article published on January 2010

Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data

artículo científico publicado en 2004

Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hep

artículo científico publicado en 2017

Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France

artículo científico publicado en 2016

Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort study

artículo científico publicado en 2010

Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis

artículo científico publicado en 2014

Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis

artículo científico publicado en 2010

Efficacy and safety of simeprevir with PegIFN/ribavirin in naïve or experienced patients infected with chronic HCV genotype 4.

artículo científico publicado en 2015

Efficacy and safety of sofosbuvir-based therapies in patients with advanced liver disease in a real-life cohort

artículo científico publicado en 2017

Efficacy and safety of two-dose regimens of peginterferon alpha-2a compared with interferon alpha-2a in chronic hepatitis C: a multicenter, randomized controlled trial

artículo científico publicado en 2004

Efficacy of Tenofovir Disoproxil Fumarate At 240 Weeks in Patients With Chronic Hepatitis B With High Baseline Viral Load ⬇️

artículo científico publicado el 3 de mayo de 2013

Efficacy of an interferon- and ribavirin-free regimen of daclatasvir, asunaprevir, and BMS-791325 in treatment-naive patients with HCV genotype 1 infection

artículo científico publicado en 2013

Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up

article by Corinne Castelnau et al published 2006 in Hepatology

Emergency transplantation for acute reactivation of chronic hepatitis B with high viral load: role of antiviral therapy.

artículo científico publicado en 2009

Entecavir plus tenofovir combination therapy for chronic hepatitis B in patients with previous nucleos(t)ide treatment failure.

artículo científico publicado en 2016

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

artículo científico publicado en 2016

Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.

artículo científico publicado en 2008

Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients.

artículo científico publicado en 2015

Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study

artículo científico publicado en 2007

Extra hepatic cancers are the leading cause of death in cirrhotic patients achieving HBV control or HCV eradication.

artículo científico publicado en 2018

Factors Associated With Persistent Increase in Level of Alanine Aminotransferase in Patients With Chronic Hepatitis B Receiving Oral Antiviral Therapy

artículo científico publicado en 2017

Fatal cardiomyopathy associated with pegylated interferon/ribavirin in a patient with chronic hepatitis C.

artículo científico publicado en 2006

Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients: A prospective study of 935 patients

scientific article published on 12 December 2006

Fibrosis and disease progression in hepatitis C.

artículo científico publicado en 2002

Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B

scientific article published on 10 April 2020

Further Analysis Is Required to Identify an Early Stopping Rule for Peginterferon Therapy That Is Valid for All Hepatitis B e Antigen–Positive Patients *†# ⬇️

artículo científico publicado el 1 de marzo de 2011

Future treatments for hepatitis delta virus infection

scientific article published on 01 February 2020

Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C.

artículo científico publicado en 2007

Genomics and HCV infection: Progression of fibrosis and treatment response ⬇️

artículo científico publicado el 30 de mayo de 2012

HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B.

artículo científico publicado en 2008

HBsAg Quantification to Predict Natural History and Treatment Outcome in Chronic Hepatitis B Patients ⬇️

artículo científico publicado el 27 de junio de 2013

HBsAg quantification to optimize treatment monitoring in chronic hepatitis B patients

artículo científico

HBsAg quantification: useful for monitoring natural history and treatment outcome

artículo científico publicado en 2014

HCV direct-acting antiviral agents: the best interferon-free combinations

artículo científico publicado en 2014

HCV non-responder patients: definition of non-response and treatment strategy

artículo científico publicado en 2007

HIV coinfection does not compromise liver histological response to interferon therapy in patients with chronic hepatitis C.

artículo científico publicado en 2002

Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis

scientific article published on 22 August 2018

Hepatitis B and hepatitis C in 2009.

artículo científico publicado en 2009

Hepatitis B e antigen status and hepatitis B DNA levels in women of childbearing age with chronic hepatitis B infection screening for clinical trials

artículo científico publicado en 2015

Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients

artículo científico publicado en 2012

Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report

scientific article published on 28 June 2011

Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients

artículo científico publicado en 2013

Hepatitis B surface antigen: association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients ⬇️

artículo científico publicado el 24 de junio de 2011

Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1.

artículo científico publicado en 2003

Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.

artículo científico publicado en 2009

Hepatitis C and liver transplantation: fibrosis progression and treatment. Or how to improve management

artículo científico publicado en 2006

Hepatitis C virus eradication followed by HBeAg to anti-HBe seroconversion after pegylated interferon-alpha2b plus ribavirin treatment in a patient with hepatitis B and C coinfection.

artículo científico publicado en 2006

Hepatitis C: The role of new interferons in the era of STAT-C.

artículo científico publicado en 2009

Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin.

artículo científico publicado en 2010

High predictive value of early viral kinetics in retreatment with peginterferon and ribavirin of chronic hepatitis C patients non-responders to standard combination therapy

artículo científico publicado en 2006

High rate of adefovir-lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France: results of a national survey in 1730 patients

artículo científico publicado en 2010

High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study

artículo científico publicado en 2009

High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials ⬇️

artículo científico publicado el 8 de agosto de 2012

IFI35, mir-99a and HCV genotype to predict sustained virological response to pegylated-interferon plus ribavirin in chronic hepatitis C.

artículo científico publicado en 2015

IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C.

artículo científico publicado en 2011

Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study

artículo científico publicado en 2015

Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.

artículo científico publicado en 2015

Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis

artículo científico publicado en 2010

Impact of ribavirin dose on retreatment of chronic hepatitis C patients

artículo científico publicado en 2012

Impact of treatment against hepatitis C virus on overall survival of naive patients with advanced liver disease

artículo científico publicado en 2014

Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir

artículo científico publicado en 2015

Improving performance of liver biopsy in fibrosis assessment

In vivo hepatic endoplasmic reticulum stress in patients with chronic hepatitis C.

artículo científico publicado en 2010

Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs

artículo científico publicado en 2018

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis

artículo científico publicado en 2016

Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B.

artículo científico publicado en 2002

Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-α2a

article by Rami Moucari et al published 2009 in Antiviral Therapy

Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naïve patients infected with HCV genotype 1 ⬇️

artículo científico publicado el 2 de marzo de 2012

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis

artículo científico publicado en 2007

Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C.

artículo científico publicado en 2013

Interferon free therapy with direct acting antivirals for HCV ⬇️

artículo científico publicado el 1 de febrero de 2013

Interferon therapy for chronic hepatitis B.

artículo científico publicado en 2007

Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI).

artículo científico publicado en 2013

Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate

artículo científico publicado en 2014

Large-scale viral genome analysis identifies novel clinical associations between hepatitis B virus and chronically infected patients

scientific article published on 19 July 2019

Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis

artículo científico publicado en 2015

Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS).

artículo científico publicado en 2015

Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection

artículo científico publicado en 2007

Liver Gene Expression Signature of Mild Fibrosis in Patients With Chronic Hepatitis C

article

Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening.

artículo científico publicado en 2018

Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT.

artículo científico publicado en 2010

Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy

artículo científico publicado en 2006

Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression

artículo científico publicado en 2015

Long-term Results of Treatment with Nucleoside and Nucleotide Analogues (Entecavir and Tenofovir) for Chronic Hepatitis B ⬇️

artículo científico publicado el 3 de julio de 2013

Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years

artículo científico publicado en 2015

Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.

artículo científico publicado en 2008

Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients.

artículo científico publicado en 2013

Long-term outcome of hepatitis C infection after bone marrow transplantation

artículo científico publicado en 2003

Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype G

artículo científico publicado en 2011

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years

artículo científico publicado en 2006

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

artículo científico publicado en 2005

Long‐term therapy for chronic hepatitis B: Hepatitis B virus DNA suppression leading to cirrhosis reversal ⬇️

artículo científico publicado el 1 de junio de 2013

Markers of Inflammation and Fibrosis in Alcoholic Hepatitis and Viral Hepatitis C ⬇️

artículo científico publicado el 22 de febrero de 2012

Mericitabine and ritonavir-boosted danoprevir with or without ribavirin in treatment-naive HCV genotype 1 patients: INFORM-SVR study

artículo científico publicado en 2014

Metabolic disorders associated with chronic hepatitis C: impact of genotype and ethnicity

artículo científico publicado en 2010

MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C.

artículo científico publicado en 2016

Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection.

artículo científico publicado en 2005

Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption

artículo científico publicado en 2007

Neutralizing antibodies to interferon‐α and circulating interferon in patients with chronic hepatitis C non‐responding to pegylated interferon plus ribavirin re‐treated by pegylated interferon‐α‐2a and ribavirin (ANRS HC16 GAMMATRI substudy*) ⬇️

artículo científico publicado el 1 de diciembre de 2010

New and emerging treatment of chronic hepatitis B.

artículo científico publicado en 2007

New direct‐acting antivirals' combination for the treatment of chronic hepatitis C ⬇️

artículo científico publicado el 1 de enero de 2011

New management strategies for hepatitis B

artículo científico publicado en 2002

No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection

artículo científico publicado en 2018

No Resistance to Tenofovir Disoproxil Fumarate Detected After up to 144 Weeks of Therapy in Patients Monoinfected With Chronic Hepatitis B Virus Δ ⬇️

artículo científico publicado el 22 de diciembre de 2010

No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B

scientific article published in PLoS ONE

No detectable resistance to tenofovir disoproxil fumarate after 6 years of therapy in patients with chronic hepatitis B ⬇️

artículo científico publicado el 1 de febrero de 2014

Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir).

artículo científico publicado en 2016

Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B

artículo científico publicado en 2008

Non-virological factors are drivers of Hepatocellular Carcinoma in virosuppressed Hepatitis B cirrhosis: results of ANRS CO12 CirVir cohort

artículo científico publicado en 2019

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.

artículo científico publicado en 2005

Occult infection of peripheral B cells by hepatitis C variants which have low translational efficiency in cultured hepatocytes.

artículo científico publicado en 2010

Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial

artículo científico publicado en 2015

Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: the randomized PILLAR study

artículo científico publicado en 2013

Optimal IFN-free therapy in treatment-naïve patients with HCV genotype 1 infection

artículo científico

Patient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepatitis C virus infection: A prospective, real-life, observational study

artículo científico publicado en 2008

Patients with chronic hepatitis C without advanced fibrosis and hepatocellular carcinoma: a retrospective clinical-pathological study

artículo científico publicado en 2014

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

artículo científico publicado en 2005

Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.

artículo científico publicado en 2004

Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3.

artículo científico publicado en 2004

Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B).

artículo científico publicado en 2015

Pegylated interferon-alpha2b plus ribavirin therapy in patients with hepatitis C and psychiatric disorders: results of a cohort study

artículo científico publicado en 2010

Pegylated interferon-α2a plus ribavirin for chronic hepatitis C in a real-life setting: the Hepatys French cohort (2003-2007).

artículo científico publicado en 2012

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

artículo científico publicado en 2004

Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status

artículo científico publicado en 2020

Pharmacokinetic/pharmacodynamic and time-to-event models of ribavirin-induced anaemia in chronic hepatitis C.

artículo científico publicado en 2005

Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C.

artículo científico publicado en 2007

Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis B.

artículo científico publicado en 2015

Predicting early and sustained virological responses in prior nonresponders to pegylated interferon alpha-2b plus ribavirin retreated with peginterferon alpha-2a plus ribavirin and the benefit-risk ratio of retreatment

artículo científico publicado en 2013

Predicting efficacy and safety outcomes in patients with hepatitis C virus genotype 1 and persistently 'normal' alanine aminotransferase levels treated with peginterferon alpha-2a (40KD) plus ribavirin

artículo científico publicado en 2007

Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.

artículo científico publicado en 2013

Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study

artículo científico publicado en 2002

Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients

artículo científico publicado en 2017

Protease and polymerase inhibitors for the treatment of hepatitis C.

artículo científico publicado en 2009

Quantification of genotype 4 serum samples: Impact of hepatitis C virus genetic variability

artículo científico publicado en 2010

Quantification of hepatitis B e antigen between Elecsys HBeAg and Architect HBeAg assays among patients infected with hepatitis B virus.

artículo científico publicado en 2013

Quantification of hepatitis B surface antigen: a new concept for the management of chronic hepatitis B ⬇️

artículo científico publicado el 1 de enero de 2011

Quasispecies analysis and in vitro susceptibility of HBV strains isolated from HIV–HBV-coinfected patients with delayed response to tenofovir

article

Randomized controlled trial of danoprevir plus peginterferon alfa-2a and ribavirin in treatment-naïve patients with hepatitis C virus genotype 1 infection

artículo científico publicado en 2013

Randomized trial of daclatasvir and asunaprevir with or without PegIFN/RBV for hepatitis C virus genotype 1 null responders

artículo científico publicado en 2013

Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trial

artículo científico publicado en 2011

Rationale and design of the REPEAT study: a phase III, randomized, clinical trial of peginterferon alfa-2a (40 kDa) plus ribavirin in non-responders to peginterferon alfa-2b (12 kDa) plus ribavirin

artículo científico publicado en 2005

Re-treatment of patients with chronic hepatitis C who do not respond to peginterferon-alpha2b: a randomized trial

artículo científico publicado en 2009

Recent advances in hepatology

artículo científico publicado en 2017

Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C

artículo científico publicado en 2014

Refined prediction of week 12 response and SVR based on week 4 response in HCV genotype 1 patients treated with peginterferon alfa-2a (40KD) and ribavirin ⬇️

artículo científico publicado el 4 de febrero de 2012

Refinement of stopping rules during treatment of hepatitis C genotype 1 infection with boceprevir and peginterferon/ribavirin

artículo científico publicado en 2012

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

artículo científico publicado en 2012

Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.

artículo científico publicado en 2008

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

artículo científico publicado en 2006

Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-up

artículo científico publicado en 2016

Reply:

Reply:

Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B.

artículo científico publicado en 2007

Resistance to adefovir: a new challenge in the treatment of chronic hepatitis B.

artículo científico publicado en 2005

Response to antiviral treatment in patients infected with hepatitis B virus genotypes E-H.

artículo científico publicado en 2009

Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: on-treatment kinetics of HBsAg serum levels vary by HBV genotype

artículo científico publicado en 2013

Response-guided therapy: optimizing treatment now and in the future.

artículo científico publicado en 2008

Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues

artículo científico publicado en 2007

Role of cytokines in the assessment of the severity of chronic hepatitis C and the prediction of response to therapy.

artículo científico publicado en 2002

Role of hepatic HCV-RNA level on the severity of chronic hepatitis C and response to antiviral therapy

artículo científico publicado en 2011

Role of replicative senescence in the progression of fibrosis in hepatitis C virus (HCV) recurrence after liver transplantation.

artículo científico publicado en 2004

Rôle protecteur accidentel de l’interféron alpha contre mycobacterium tuberculosis au cours d’un traitement anti-viral C

artículo científico publicado en 2004

SCG10 expression on activation of hepatic stellate cells promotes cell motility through interference with microtubules

artículo científico publicado en 2010

Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients

artículo científico publicado en 2016

Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials

artículo científico publicado en 2019

Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort

article

Safety and efficacy of viramidine versus ribavirin in ViSER2: randomized, double-blind study in therapy-naive hepatitis C patients.

artículo científico publicado en 2009

Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials

artículo científico publicado en 2015

Safety profile of standard- vs. high-dose peginterferon alfa-2a plus standard-dose ribavirin in HCV genotype 1/4 patients: pooled analysis from 5 randomized studies ⬇️

artículo científico publicado el 4 de septiembre de 2012

Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C.

artículo científico publicado en 2002

Second-wave IFN-based triple therapy for HCV genotype 1 infection: simeprevir, faldaprevir and sofosbuvir

artículo científico publicado en 2014

Serum Levels of Hepatitis B Surface Antigen Predict Severity of Fibrosis in Patients With E Antigen-Positive Chronic Hepatitis B.

artículo científico publicado en 2014

Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers

artículo científico publicado en 2002

Serum proteome to predict virologic response in patients with hepatitis C treated by pegylated interferon plus ribavirin

artículo científico publicado en 2006

Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapy

artículo científico publicado en 2002

Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection.

artículo científico publicado en 2014

Severity of liver disease among chronic hepatitis C patients: an observational study of 4594 patients in five European countries

artículo científico publicado en 2015

Significant gene expression differences in histologically "Normal" liver biopsies: Implications for control tissue

artículo científico publicado en 2008

Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial

artículo científico publicado en 2014

Sofosbuvir-based regimens are suboptimal in patients with genotype 2 chronic hepatitis C infection: Real-life experience from the HEPATHER ANRS CO22 cohort

scientific article published on 21 May 2020

Solitary pulmonary metastasis arising thirteen years after liver transplantation for HBV-related hepatocellular carcinoma.

artículo científico publicado en 2006

Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3.

artículo científico publicado en 2011

Sustained hepatitis B e antigen seroconversion in patients with chronic hepatitis B after adefovir dipivoxil treatment: analysis of precore and basal core promoter mutants

artículo científico publicado en 2008

Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a

artículo científico publicado en 2009

Sustained virological response after 14-day treatment with danoprevir and 48-week treatment with pegylated interferon-α2a (40 KD) plus ribavirin

artículo científico publicado en 2012

Sustained virological response is associated with clearance of hepatitis C virus RNA and a decrease in hepatitis C virus antibody

artículo científico publicado en 2009

Telaprevir is effective given every 8 or 12 hours with ribavirin and peginterferon alfa-2a or -2b to patients with chronic hepatitis C.

artículo científico publicado en 2010

Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy

artículo científico publicado en 2014

Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection

artículo científico publicado en 2019

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.

artículo científico publicado en 2016

Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml).

artículo científico publicado en 2014

Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.

artículo científico publicado en 2008

Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection.

artículo científico publicado en 2010

The Usefulness of Defining Rapid Virological Response by a Very Sensitive Assay (TMA) during Treatment of HCV Genotype 2/3 Infection

artículo científico publicado en 2015

The combination of MK-5172, peginterferon, and ribavirin is effective in treatment-naive patients with hepatitis C virus genotype 1 infection without cirrhosis

artículo científico publicado en 2014

The current status of antiviral therapy of chronic hepatitis B.

artículo científico publicado en 2005

The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report.

artículo científico publicado en 2009

The predictive value of core antigen testing for the management of hepatitis C patients receiving pegylated interferon/ribavirin treatment

artículo científico publicado en 2004

The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C.

artículo científico publicado en 2012

The role of HBsAg quantification for monitoring natural history and treatment outcome ⬇️

artículo científico publicado el 1 de febrero de 2013

Things fall apart with hepatocellular carcinoma and direct-acting antivirals.

artículo científico publicado en 2017

Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.

artículo científico publicado en 2010

Towards the eradication of hepatitis C virus ⬇️

artículo científico publicado el 1 de febrero de 2012

Transient elastography in chronic viral hepatitis: a critical appraisal.

scientific article published on 29 March 2011

Transition of care between paediatric and adult gastroenterology. Chronic viral hepatitis

artículo científico publicado en 2003

Treatment of chronic hepatitis B with the combination of pegylated interferon with lamivudine

scientific article published on 01 July 2007

Treatment of chronic hepatitis C patients with the NS3/4A protease inhibitor danoprevir (ITMN-191/RG7227) leads to robust reductions in viral RNA: a phase 1b multiple ascending dose study.

artículo científico publicado en 2011

Treatment of hepatitis B e antigen positive chronic hepatitis with telbivudine or adefovir: a randomized trial

artículo científico publicado en 2007

Treatment of hepatitis C virus genotype 4-related cirrhosis: ribavirin and interferon combination compared with interferon alone

artículo científico publicado en 2002

Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?

artículo científico publicado en 2018

Treatment of patients with chronic hepatitis C who have not been previously treated

artículo científico publicado en 2002

Treatment of viral hepatitis: a new era ⬇️

artículo científico publicado el 1 de febrero de 2013

Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials

artículo científico publicado en 2015

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.

artículo científico publicado en 2013

Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin

artículo científico publicado en 2010

Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patients

artículo científico publicado en 2014

Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy

scientific article published on 13 February 2019

Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: A randomized phase II study ⬇️

artículo científico publicado el 17 de julio de 2012

Viral hepatitis in 2011: a major step forward ⬇️

artículo científico publicado el 1 de enero de 2011

Viral hepatitis: impressive advances but still a long way to eradication of the disease

artículo científico publicado en 2014

Viral hepatitis: towards the eradication of HCV and a cure for HBV.

artículo científico publicado en 2016

Viral hepatitis: towards the eradication of HCV and a cure for HBV.

artículo científico publicado en 2015

Viral suppression and cirrhosis regression with tenofovir disoproxil fumarate in Asians with chronic hepatitis B.

artículo científico publicado en 2014

Virological and serological tools to optimize the management of patients with chronic hepatitis B.

artículo científico

Virological response at 4 weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirin

artículo científico publicado en 2009

What is the safe duration of therapy for patients infected with HCV genotype 6?

artículo científico publicado en 2008

Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the 'accordion' regimen?

artículo científico publicado en 2007

[Assessment of hepatitis C networks]

artículo científico publicado en 2002

[Hepatitis B: clinical application of HBsAg quantification]

artículo científico publicado en 2013

[Hepatitis C in 2007...progress and challenges]

scientific article published on 01 August 2007

[Management of hepatitis B and C]

artículo científico publicado en 2005

[Managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B]

artículo científico publicado en 2006

[Steatosis during chronic hepatitis C: the role of insulin resistance and viral factors]

artículo científico publicado en 2007

[Treatment of chronic hepatitis B]

scientific article published on 01 December 2004

[Treatment of chronic hepatitis B]

artículo científico publicado en 2005

[Treatment of chronic hepatitis B]

artículo científico publicado en 2006

[Treatment of chronic hepatitis B]

artículo científico publicado en 2011

[What does chronic hepatitis C steatosis mean?]

artículo científico publicado en 2003

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda